4//SEC Filing
Sethuraman Natarajan 4
Accession 0001689375-24-000057
CIK 0001689375other
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 4:31 PM ET
Size
4.9 KB
Accession
0001689375-24-000057
Insider Transaction Report
Form 4
Sethuraman Natarajan
President, Research & Develop.
Transactions
- Sale
Common Stock
2024-10-16$18.00/sh−600$10,800→ 183,216 total
Footnotes (1)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2023.
Documents
Issuer
Entrada Therapeutics, Inc.
CIK 0001689375
Entity typeother
Related Parties
1- filerCIK 0001873394
Filing Metadata
- Form type
- 4
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 4:31 PM ET
- Size
- 4.9 KB